Chemist + Druggist is part of Pharma Intelligence UK Limited

This is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.


This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction

PSNC to discuss future of MURs in upcoming contract negotiations

Discussions around the future of the medicines use review (MUR) service will form part of upcoming contract negotiations, PSNC has said.

The number of MURs contractors can deliver will be capped at 200 from April 1 to September 30, as part of interim funding arrangements announced by the Pharmaceutical Services Negotiating Committee (PSNC) this afternoon (March 8). 

Explaining the cap, PSNC said: "Further discussions about the [MUR] service will form part of the wider [contract] negotiations."

PSNC hopes to begin these negotiations "in the next month", during which it has previously said it will propose a service-based contract, a move to a multi-year settlement and funding for the implementation of the EU scanning law – the Falsified Medicines Directive.

It "hopes that any substantive changes to the community pharmacy contractual framework will be agreed in time to be implemented from October", PSNC added.

Single activity fee may be adjusted

As part of the interim funding arrangements anounced today, funding for England’s pharmacies will remain at its current level of £2.592 billion.

The single activity fee "will be set to continue to deliver funding at this rate", the negotiator said.

However, the level is "still under discussion with the Department of Health and Social Care, and as such, may be adjusted later this year".

Are you satisfied with the current MUR service?

Related Content

Topics

         
Pharmacist Manager
Barnsley
£30 per hour

Apply Now
Latest News & Analysis
See All
UsernamePublicRestriction

Register

CD005791

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel